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Background: Merkel cell carcinoma (MCC) is an uncommon neuroendocrine cutaneous carcinoma. Metastases to
the thyroid gland are rare and may present diagnostic difficulties.
Case presentation: A 73-year-old woman presented with a hard mass in the adipose tissue of the right inguinal
area. This mass was surgically excised and the histology examination showed the existence of a MCC. CT scans
revealed a sizable lesion with imaging features of a submerged goiter, invasive to the upper mediastinum. The
patient received chemotherapy following by locoregional radiotherapy at the bed of the excised lesion. During the
next 10 months the patient was asymptomatic, serum markers values were normal and CT scans findings were
stable. However, afterwards NSE and chromogranin values raised and CT scans revealed an enlargement of the
submerged goiter. The patient became symptomatic, mainly experiencing respiratory inconvenience. Surgical
excision of the right lobe of the thyroid gland was decided and performed without any complications. The
histopathology examination showed infiltration of the thyroid gland by a neuroendocrine carcinoma with
characteristics compatible with MCC.
Conclusions: The rare case of metastatic infiltration of the thyroid gland by a MCC based on histological and
immunohistochemical findings was described. This case report is of clinical significance indicating that by any
abnormal finding in the thyroid gland in patients with a malignant disease, the diagnostic approach should always
contain consideration of metastasis from the primary tumor.
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Merkel Cell Carcinoma (MCC) is an uncommon neuro-
endocrine cutaneous carcinoma which is characterized
by high incidence of early loco-regional relapse and distant
metastases (Poulsen 2004).Case presentation
A 73-year-old woman with no prior medical history,
presented with a hard mass (diameter = 46 mm) in the
adipose tissue of the right inguinal area which was con-
firmed by CT scan (Nov 2009). A month later, this mass* Correspondence: tsoukn@yahoo.gr
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in any medium, provided the original work is pwas surgically excised and the histology examination
showed a poorly differentiated small cell carcinoma, with
histopathologic features of a Merkel cell carcinoma. CT
scans revealed a sizable lesion with imaging features of
a submerged goiter, invasive to the upper mediastinum
(diameter = 66 mm) with no enlarged mediastinal or axil-
lary lymph nodes (Figures 1: large mass in the right lobe
of thyroid grand invasive to the upper mediastinum). At
the time no further diagnostic evaluation of the sub-
merged goiter took place.
Afterwards, the patient was admitted to our department
for further clinical evaluation and treatment. Serum NSE
and chromogranin values were 21,8 ng/ml (< 16,3 ng/ml)
and 7,6 ng/ml (< 5,6 ng/ml) respectively. Initially, the
patient received chemotherapy with the regimen cisplatinis an open access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 CT scan large mass in the right lobe of thyroid grand invasive to the upper mediastinum.
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every 3 weeks) following by locoregional radiotherapy
at the bed of the excised lesion (total dose 45 Gy). Both
of these treatments were well tolerated. Three months
later (Jan 2011) serum NSE and chromogranin values were
within normal limits and the subsequent CT scans revealed
stable disease. During the next 10 months the patient was
asymptomatic, serum markers values were normal and CT
scans findings were still stable.
However, in November 2011 follow up NSE and chromo-
granin values raised to 26 ng/ml and 9,2 ng/ml respectively.In addition to that, CT scans revealed an enlarge-
ment of the submerged goiter which was invasive
to the upper mediastinum, displacing trachea to
the left, still without enlarged mediastinal or axillary
lymph nodes again. Moreover, an ultrasound of the
thyroid gland confirmed a significant increase of the
size of the submerged right lobe. The patient became
symptomatic, mainly experiencing respiratory incon-
venience. Surgical excision of the right lobe of the
thyroid gland was decided and performed without
any complications.
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the thyroid gland by a neuroendocrine carcinoma with
characteristics compatible with Merkel cell carcinoma.
The tumor consisted of uniform, small to medium
sized cells with a round nucleus, finely dispersed chro-
matin, inconspicuous nucleoli and scant cytoplasm
(Figure 2: hematoxylin-eosin-staining H-E showing both
thyroid follicles in the down left part and tumor cells in
the upper right part, original magnification ×100). There
were numerous mitoses and areas with necrosis. The tumor
was characterized of positive immunohistochemical reac-
tion for antibodies to cytokeratin CAM 5.2, cytokeratin
20 CK20 (Figure 3: immunoperoxidase staining for CK20
showing positive tumor cells, original magnification ×400),
neurofilaments NF (Figure 4: immunoperoxidase staining
for NF showing positive tumor cells, original magnifica-
tion ×400) and neuroendocrine markers chromogranin,
synaptophysin and CD56. Immunohistochemical reaction
for antibodies to TTF-1 was negative.
After the surgery the patient was asymptomatic. The
serum NSE and chromogranin values were within normal
limits and the subsequent CT scans were normal without
any evidence of remaining disease. Consequently, despite
the aggressive nature of this metastatic neoplasm, the
patient remained in complete remission following a
multidisciplinary approach for a long period of time.
Discussion
Merkel cell carcinoma is a rare neuroendocrine tumor
of the skin, accounting for less than 1% of cutaneous
malignancies. The origin of this cutaneous neuroendocrineFigure 2 H-E staining showing both thyroid follicles in the down left
magnification ×100.tumor is thought to be the Merkel cells or the skin-
pressure receptors (Poulsen 2004). Merkel cell carcin-
oma tends to grow fast and metastasize to other parts
of the body. Usually it spreads to nearby lymph nodes
initially and then may spread to liver, bone, lungs or
brain, where it can interfere with the functioning of this
organs (Tai et al. 2000a). Even under treatment, this type
of carcinoma commonly metastasizes beyond skin. The
treatment of this tumor should be based on a multidisciplin-
ary approach with surgery, chemotherapy and radiotherapy
(Eng et al. 2007; Ott et al. 1999; Eng et al. 2004a; Eng et al.
2004b). First of all the surgical remove of the tumor is very
important and should take place when it is feasible. Add-
itionally, chemotherapy regimens like cisplatin-etoposide
(or carboplatin-etoposide, topotecan, CAV) can be used
and radiotherapy can be administered in the specific
involved fields (Tai et al. 2000b; Fenig et al. 1997).
Metastases to the thyroid gland are rare and may
present diagnostic difficulties not only in the cytological
specimens but also in the histological specimens. The
most common primary tumors that metastasise to the
thyroid gland are kidney cancers, colorectal cancers, lung
cancers, breast cancers and sarcomas (Chung et al. 2012).
In fact, metastasis from Merkel cell carcinoma to the
thyroid gland is an exceptionally rare clinical condi-
tion. A rigorous search of the literature disclosed only
one similar case in which the confirmation of the thy-
roid gland infiltration was based on the findings of fine
needle aspiration FNA (Stoll et al. 2010).
Therefore, the present case is very interesting and unique
because the diagnosis of the metastatic infiltration ofpart and tumor cells in the upper right part, original
Figure 3 Immunoperoxidase staining for CK20 showing positive tumor cells, original magnification ×400.
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the histological findings on the surgical removed right thy-
roid lobe. During the diagnostic approach, apart from the
general morphology findings in the hematoxylin-eosin-
staining, the role of immunohistochemistry was very help-
ful. In particular, immunohistochemical stains for CK20,
TTF-1 and neurofilaments are useful markers for the im-
munohistochemical distinction between Merkel cell car-
cinoma from small cell carcinoma of the lung (Leech
et al. 2001; Bobos et al. 2006). More specifically, Merkel
cell carcinoma is positive for the immunohistochemical
antibodies to CK20 and NF and negative for TTF1 whileFigure 4 Immunoperoxidase staining for NF showing positive tumorsmall cell carcinoma is positive for TTF1 and negative
for CK20 and NF (Bobos et al. 2006).Conclusions
In conclusion, the rare case of metastatic infiltration of the
thyroid gland by a Merkel cell carcinoma based on histo-
logical and immunohistochemical findings was described.
This case report is of clinical significance indicating that by
any abnormal finding in the thyroid gland in patients with a
malignant disease, the diagnostic approach should always
contain consideration of metastasis from the primary tumor.cells, original magnification ×400.
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